| Tissue Specificity | Plasma. Expressed primarily in liver. |
| Post Translational Modifications | Glycosylated. O-fucosylated by POFUT2 on a serine or a threonine residue found within the consensus sequence C1-X(2)-(S/T)-C2-G of the TSP type-1 repeat domains where C1 and C2 are the first and second cysteine residue of the repeat, respectively. Fucosylated repeats can then be further glycosylated by the addition of a beta-1,3-glucose residue by the glucosyltransferase, B3GALTL. Fucosylation mediates the efficient secretion of ADAMTS13. May also be C-glycosylated on tryptophan residues within the consensus sequence W-X-X-W of the TPRs, and also N-glycosylated. These other glycosylations can also facilitate secretion. The precursor is processed by a furin endopeptidase which cleaves off the pro-domain. |
| Function | Cleaves the vWF multimers in plasma into smaller forms thereby controlling vWF-mediated platelet thrombus formation. |
| Protein Name | A Disintegrin And Metalloproteinase With Thrombospondin Motifs 13Adam-Ts 13Adam-Ts13Adamts-13Von Willebrand Factor-Cleaving ProteaseVwf-CpVwf-Cleaving Protease |
| Database Links | Reactome: R-HSA-5083635Reactome: R-HSA-5173214Reactome: R-HSA-75892Reactome: R-HSA-9845619Reactome: R-HSA-9845621 |
| Cellular Localisation | SecretedSecretion Enhanced By O-Fucosylation Of Tsp Type-1 Repeats |
| Alternative Antibody Names | Anti-A Disintegrin And Metalloproteinase With Thrombospondin Motifs 13 antibodyAnti-Adam-Ts 13 antibodyAnti-Adam-Ts13 antibodyAnti-Adamts-13 antibodyAnti-Von Willebrand Factor-Cleaving Protease antibodyAnti-Vwf-Cp antibodyAnti-Vwf-Cleaving Protease antibodyAnti-ADAMTS13 antibodyAnti-C9orf8 antibodyAnti-UNQ6102 antibodyAnti-PRO20085 antibody |
Information sourced from Uniprot.org
